Investigates the impact of aging on spinal cord atrophy in multiple sclerosis, suggesting the need for targeted interventions.
Spinal cord atrophy is a key predictor of clinical disability and disease progression in MS. The distinct contributions of physiological aging versus MS-related neurodegeneration remain poorly characterized.
No takes yet. Share an insight, caveat, or question.
Rocca et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: